rs1343151

Variant summary

Our verdict is . The variant received -12 ACMG points: 0P and 12B. BA1BP4_Strong

The NM_144701.3(IL23R):c.1149-2391G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.404 (AC=61,408) in the gnomAD database across 152,018 control chromosomes, including 15,100 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.674. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 15100 hom., cov: 32)

Consequence

IL23R
NM_144701.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0970

Publications

108 publications found
Variant links:
Genes affected
IL23R (HGNC:19100): (interleukin 23 receptor) The protein encoded by this gene is a subunit of the receptor for IL23A/IL23. This protein pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner. [provided by RefSeq, Jul 2008]
IL23R Gene-Disease associations (from GenCC):
  • immunodeficiency disease
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • inherited susceptibility to mycobacterial diseases
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_144701.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.6737 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_144701.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL23R
NM_144701.3
MANE Select
c.1149-2391G>A
intron
N/ANP_653302.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL23R
ENST00000347310.10
TSL:1 MANE Select
c.1149-2391G>A
intron
N/AENSP00000321345.5Q5VWK5-1
IL23R
ENST00000425614.3
TSL:1
c.384-2391G>A
intron
N/AENSP00000387640.2Q5VWK5-6
IL23R
ENST00000473881.2
TSL:1
n.191-2391G>A
intron
N/AENSP00000486667.1A0A0D9SFJ7

Frequencies

GnomAD3 genomes
AF:
0.404
AC:
61345
AN:
151900
Hom.:
15079
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.681
Gnomad AMI
AF:
0.404
Gnomad AMR
AF:
0.291
Gnomad ASJ
AF:
0.299
Gnomad EAS
AF:
0.0550
Gnomad SAS
AF:
0.150
Gnomad FIN
AF:
0.211
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.342
Gnomad OTH
AF:
0.364
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.404
AC:
61408
AN:
152018
Hom.:
15100
Cov.:
32
AF XY:
0.390
AC XY:
28946
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.680
AC:
28212
AN:
41468
American (AMR)
AF:
0.290
AC:
4431
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.299
AC:
1037
AN:
3470
East Asian (EAS)
AF:
0.0547
AC:
283
AN:
5174
South Asian (SAS)
AF:
0.150
AC:
721
AN:
4816
European-Finnish (FIN)
AF:
0.211
AC:
2230
AN:
10550
Middle Eastern (MID)
AF:
0.320
AC:
94
AN:
294
European-Non Finnish (NFE)
AF:
0.342
AC:
23269
AN:
67952
Other (OTH)
AF:
0.362
AC:
763
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1627
3254
4881
6508
8135
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
546
1092
1638
2184
2730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.364
Hom.:
39712
Bravo
AF:
0.423
Asia WGS
AF:
0.179
AC:
625
AN:
3476

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.105
AC:
12889
AN:
122680
Turkish Variome
AF:
0.281
AC:
434
AN:
1546
Hom.:
64
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.0301
AC:
270
AN:
8960
Hom.:
5
ABraOM SABE-WGS-1171
AF:
0.403
AC:
944
AN:
2342
Hom.:
195

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
3.9
DANN
Benign
0.83
PhyloP100
-0.097
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.